18.06.2024 16:00:00
|
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).Both companies have a long history of paying dividends and offer attractive yields, making them popular choices among income-seeking investors. However, when comparing these two stocks, several factors should be considered to determine which one is the better high-yield dividend investment.Image Source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol Myers Squibb CoUSD 2.00 Cum.Conv.Pfd Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Bristol Myers Squibb CoUSD 2.00 Cum.Conv.Pfd Shsmehr Analysen
Aktien in diesem Artikel
Bristol Myers Squibb CoUSD 2.00 Cum.Conv.Pfd Shs | 1 040,41 | -2,38% |
|
Bristol-Myers Squibb Co. | 55,09 | -2,11% |
|
Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs | 7 980,00 | -2,33% |
|
Pfizer Inc. | 23,64 | -0,59% |
|